Legal status · Canada
Is Icotrokinra legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Icotrokinra is not an approved medicine in Canada; its classification is "Prescription only; check current Health Canada status". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Icotrokinra in Canada at a glance
| Classification | Prescription only; check current Health Canada status |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Icotrokinra profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Icotrokinra is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Icotrokinra is
A 13 amino acid peptide taken as a tablet that blocks the IL-23 receptor. The first oral drug to hit that pathway, in a class that was injection only.
Interleukin-23 drives plaque psoriasis, and the drugs that block it are among the most effective treatments there are. All of them were injected antibodies.
Mechanism: Binds the IL-23 receptor with picomolar affinity and blocks IL-23 signalling. Conventional IL-23 drugs are antibodies that bind the cytokine itself; this binds the receptor, and its small peptide size is what makes oral dosing possible.
Regulatory history: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Icotrokinra at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Icotrokinra in other countries
United States
Not approvedPrescription only; FDA approved
Is Icotrokinra legal in the United States?United Kingdom
Not approvedPrescription only; check current MHRA status
Is Icotrokinra legal in the United Kingdom?Australia
Not approvedPrescription only; check current TGA status
Is Icotrokinra legal in Australia?Frequently asked questions
Is Icotrokinra legal in Canada?
No. Icotrokinra is not an approved medicine in Canada; its classification is "Prescription only; check current Health Canada status". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy Icotrokinra in Canada?
No approved product exists to buy. In Canada Icotrokinra is classified as "Prescription only; check current Health Canada status", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Icotrokinra Health Canada approved?
No. In Canada Icotrokinra is classified as "Prescription only; check current Health Canada status", which is not a Health Canada marketing approval. For comparison, the US FDA status is: FDA approved 2026 for moderate to severe plaque psoriasis. Prescription only.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Icotrokinra live on its compound profile.
Icotrokinra profileThis page is general information about the regulatory status of Icotrokinra in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.